The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

NCT05961709 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Cemiplimab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]